Julie S Braun, PA | |
2780 W Horizon Ridge Pkwy Ste 30, Henderson, NV 89052-3995 | |
(702) 420-9551 | |
Not Available |
Full Name | Julie S Braun |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Experience | 23 Years |
Location | 2780 W Horizon Ridge Pkwy Ste 30, Henderson, Nevada |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396745873 | NPI | - | NPPES |
1396745873 | Medicaid | NV | |
320311 | Medicaid | AZ | |
DL549Z | Other | NV | MEDICARE PTAN |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mavis N Matsumoto Md Llc | 6800065012 | 2 |
News Archive
A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance.
The Obama administration's final rule rescinding important elements of a federal regulation protecting the conscience rights of health care providers is a disappointment, but there are also reasons for hope, said Deirdre McQuade of the Pro-Life Secretariat of the United States Conference of Catholic Bishops (USCCB).
Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.
The amount of data produced each year by scientific user facilities such as those at national labs or government organizations can range up to several billion gigabytes per year.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Julie S Braun, PA 2780 W Horizon Ridge Pkwy Ste 30, Henderson, NV 89052-3995 Ph: (702) 992-4050 | Julie S Braun, PA 2780 W Horizon Ridge Pkwy Ste 30, Henderson, NV 89052-3995 Ph: (702) 420-9551 |
News Archive
A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance.
The Obama administration's final rule rescinding important elements of a federal regulation protecting the conscience rights of health care providers is a disappointment, but there are also reasons for hope, said Deirdre McQuade of the Pro-Life Secretariat of the United States Conference of Catholic Bishops (USCCB).
Vertex Pharmaceuticals Incorporated today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb Company to conduct Phase 2 studies of once-daily all-oral treatment regimens containing Vertex's nucleotide analogue hepatitis C virus polymerase inhibitor VX-135 and Bristol-Myers Squibb's NS5A replication complex inhibitor daclatasvir for the treatment of hepatitis C.
The amount of data produced each year by scientific user facilities such as those at national labs or government organizations can range up to several billion gigabytes per year.
› Verified 5 days ago